Buy This Top Stock on a Pullback

Popular Posts:

• 6 Stocks to Sell in June
• Chances Are High Stocks Will Rebound Today
• Top 6 Stocks to Buy for June

Recent Posts:

• The Bull Is on the Move, Especially in Small Caps
• New Bullish Pattern Developing on This Semi Stock’s Chart
• Why You Shouldn’t Heed Calls of a Market Top
• View All Posts

Cubist Pharmaceuticals (NASDAQ:CBST) — This pharmaceutical company focuses on research and development in the acute-care environment. Drugs to combat hospital-acquired infections are its priority.

This year’s earnings could be flat at $1.84, but the approval of several potential blockbuster drugs could contribute to an earnings increase. In early August, Goldman Sachs initiated coverage on the stock with a “buy” rating and a $54 price target.

Technically the breakout from a triple-top on high volume and a stochastic “buy” are noteworthy.

Since we placed CBST on our list of Top Stocks to Buy for September, it is up several points and the stochastic is slightly overbought. It would be wise to only take new positions on a pullback to $45. The target remains at $52.

Click to Enlarge